Lipid nanoparticles for gene therapy
(PHYSorg.com Nanotechnology)

Lipid nanoparticles (SLNs and NLCs) are regarded as highly promising systems for delivering nucleic acids in gene therapy. Until now, viral systems have been the most effective method for delivering genetic matter but they pose significant safety problems. `Non-viral vectors, including SLNs and NLCs, are less effective but much safer even though their effectiveness has increased significantly in recent years,` pointed out Alicia Rodríguez, María Ángeles Solinís and Ana del Pozo, authors of the article published in the European Journal of Pharmaceutics and Biopharmaceutics.